내시경 장비 시장 : 제품별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The global endoscopy equipment market is projected to grow from USD 37.08 billion in 2025 to USD 53.54 billion by 2030, at a CAGR of 7.6% during the forecast period. The growth of the endoscopy equipment market is driven by the rising demand for endoscopic procedures to diagnose and manage target conditions such as colorectal cancer and inflammatory bowel diseases, fueled by increasing disease prevalence and the need for early, minimally invasive interventions. Market opportunities are emerging from the growing adoption of single-use endoscopes, which help address infection control concerns. Additionally, the rapid expansion of healthcare infrastructure in emerging economies presents untapped potential. These regions are experiencing increased investments, improved access to healthcare, and evolving standards of patient care.

However, market growth is restrained by high device costs, risk of cross-contamination despite reprocessing, and the availability of alternative diagnostic techniques. Additionally, a lack of skilled professionals and regulatory challenges in some regions hamper broader market penetration.

"Flexible endoscopes segment is expected to hold the largest market share during the forecast period"

Based on product, the endoscopy equipment market is segmented into endoscopes, visualization systems, other endoscopy equipment, and accessories. The endoscopes segment is further bifurcated into flexible endoscopes, rigid endoscopes, robot-assisted endoscopes, and capsule endoscopes. Among these in 2024, the flexible endoscopes segment accounted for the largest market share, due to their broad applicability, superior maneuverability, and preference in minimally invasive diagnostic and therapeutic procedures. This dominance is projected to continue during the forecast period.

Flexible endoscopes are widely used across gastrointestinal, pulmonary, urological, and gynecological applications, offering enhanced patient comfort and access to complex anatomical structures compared to rigid alternatives. Their ability to provide high-resolution imaging with greater precision supports early disease detection and effective treatment, driving higher adoption among healthcare providers. The rising global burden of gastrointestinal disorders, cancer screening programs, and the growing preference for outpatient endoscopic procedures further strengthen demand. Additionally, ongoing innovations such as disposable and single-use flexible endoscopes address concerns around cross-contamination and reprocessing costs, making them highly attractive to hospitals and ambulatory surgery centers. These factors collectively position flexible endoscopes as the most dominant segment in the endoscopy equipment market.

"Laparoscopy segment is projected to hold the second-largest market during the forecast period"

The laparoscopy segment accounted for the second largest share of the market in 2024 and is expected to lead during the forecast period. This is due to its widespread adoption as the preferred surgical approach across multiple therapeutic areas. For instance, according to the National Library of Medicine (October 2023), laparoscopic procedures demonstrate statistically significant advantages over traditional open surgeries, including shorter operative times, reduced blood loss, quicker recovery, and shorter hospital stays, making them highly favorable for patients and healthcare providers.

The rapid rise in obesity prevalence has further accelerated demand for laparoscopic bariatric procedures, as they ensure long-term survival and deliver substantial metabolic benefits. The increasing patient preference for reduced scarring and faster recovery continues to fuel this segment's growth, securing its strong position as the second-largest contributor within the endoscopy equipment market.

"Asia Pacific region is expected to grow at the fastest rate, while North America is projected to hold the largest share during the forecast period"

The global endoscopy equipment market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among these, the Asia Pacific region is expected to grow at the fastest rate due to the healthcare infrastructure development, increasing healthcare expenditure, and rising awareness of early disease detection across China and India. These countries are investing heavily to enhance diagnostic and surgical capabilities, particularly to manage rising cases of chronic diseases such as cancer and cardiovascular disorders. Japan's well-established healthcare system with universal insurance coverage ensures wide accessibility to advanced endoscopic procedures. Moreover, increasing medical tourism, favorable government initiatives, and the rising adoption of minimally invasive technologies are accelerating market penetration, making Asia Pacific a high-growth region in the global endoscopy equipment market.

The North American endoscopy equipment market is primarily dominated by the US, driven by favorable reimbursement policies, advanced healthcare infrastructure, and high disease prevalence. Robust coverage for endoscopic procedures under Medicare and private insurance significantly reduces patient out-of-pocket costs, leading to increased adoption of endoscopy equipment in hospitals and outpatient settings.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
• By Designation: C-level - 50%, Director level - 30%, and Others - 20%
• By Region: North America - 30%, Europe - 25%, Asia Pacific - 20%, Latin America - 15%, and Middle East & Africa - 10%.

The players operating in the endoscopy equipment market include Olympus Corporation (Japan), Karl Storz SE & CO. Kg (Germany), Boston Scietific Corporation (US), FUJIFILM Corporation (Japan), HOYA Corporation (Japan), Stryker (US), Medtronic (Ireland), Smith+Nephew (UK), Johnson & Johnson (US), Nipro (Japan), Steris (US), B Braun SE (Germany), Conmed Corporation (US), Ambu A/S (Denmark), Cook Medical (US), Hologic Inc. (US), EndoMed Systems GmbH (Germany), Richard Wolf GmbH. (Germany), CapsoVision, Inc. (US), Teleflex Incorporated (US), Laborie (US), Arthrex, Inc. (US), Dantschke Medizintechnik GMBH & Co. KG (Germany), The Cooper Companies, Inc. (US), and SonoScape Medical Corp (China).

Research Coverage

This report studies the endoscopy equipment market based on type, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the strategies mentioned below to strengthen their market presence.

This report provides insights into the following pointers.

• Analysis of key drivers (The increasing requirement for endoscopy to diagnose and treat target diseases, Surging incidence of inflammatory bowel diseases and colorectal cancer, Rising focus of medical specialists to shift from manual to automated endoscopy reprocessing), restraints (High overhead costs of endoscopy procedures with limited reimbursement in emerging economies, Increasing risk of getting infections during endoscopic procedures), opportunities (Rapidly developing healthcare sector in emerging economies, Increasing adoption of single-use endoscopes), challenges (Increasing number of product recalls, Lack of proper sterilization and reprocessing, Shortage of trained physicians and endoscopists)
• Market Penetration: Complete knowledge of the spectrum of products presented by the major companies in the endoscopy equipment market
• Product Development/Innovation: Comprehensive understanding of the forthcoming trends, research and development initiatives, and product launches within the endoscopy equipment market
• Market Development: Complete knowledge about profitable developing regions
• Market Diversification: Exhaustive knowledge of new goods, expanding geographies, and current changes in the endoscopy equipment industry help to diversify the market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players, such as Olympus Corporation (Japan), Karl Storz SE & CO. Kg (Germany), Boston (US), FUJIFILM Corporation (Japan), HOYA Corporation (Japan), Stryker (US), and Ambu A/S (Denmark)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS
• 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Key industry insights
• 2.2 MARKET SIZE ESTIMATION
  • 2.2.1 APPROACH 1: SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
  • 2.2.2 APPROACH 2: TOP-DOWN APPROACH
  • 2.2.3 APPROACH 3: COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
  • 2.2.4 APPROACH 4: DEMAND-SIDE ANALYSIS (USING ENDOSCOPY EQUIPMENT)
• 2.3 GROWTH FORECAST MODEL
• 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.5 MARKET RANKING ANALYSIS
• 2.6 RESEARCH ASSUMPTIONS
• 2.7 RESEARCH LIMITATIONS
  • 2.7.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.7.2 SCOPE-RELATED LIMITATIONS
• 2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 ENDOSCOPY EQUIPMENT MARKET OVERVIEW
• 4.2 NORTH AMERICA: ENDOSCOPY EQUIPMENT MARKET, BY END USER & COUNTRY
• 4.3 REGIONAL MIX: ENDOSCOPY EQUIPMENT MARKET
• 4.4 GEOGRAPHIC MIX: ENDOSCOPY EQUIPMENT MARKET, 2025-2030
• 4.5 ENDOSCOPY EQUIPMENT MARKET: EMERGING ECONOMIES VS. DEVELOPED MARKETS, 2025 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising investments, funds, and grants for endoscopy procedures
    • 5.2.1.2 Increasing preference for minimally invasive surgeries
    • 5.2.1.3 Growing incidence of inflammatory bowel disease and colorectal cancer
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High overhead costs
    • 5.2.2.2 Risk of viral infections
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Rapidly developing healthcare sector in emerging economies
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Product recalls
    • 5.2.4.2 Lack of proper sterilization and reprocessing
• 5.3 INDUSTRY TRENDS
  • 5.3.1 AI AND IMAGE-GUIDED SOLUTIONS
  • 5.3.2 INTEGRATION OF DIGITAL PLATFORMS AND CONNECTIVITY
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 5.5 PRICING ANALYSIS
  • 5.5.1 AVERAGE SELLING PRICING TREND, BY KEY PLAYER
  • 5.5.2 AVERAGE SELLING PRICING TREND, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 SUPPLY CHAIN ANALYSIS
• 5.8 ECOSYSTEM ANALYSIS
• 5.9 INVESTMENT AND FUNDING SCENARIO
• 5.10 TECHNOLOGY ANALYSIS
  • 5.10.1 KEY TECHNOLOGIES
    • 5.10.1.1 High-definition (HD) and 4K imaging sensors
  • 5.10.2 COMPLEMENTARY TECHNOLOGIES
    • 5.10.2.1 Artificial Intelligence (AI) and image processing
  • 5.10.3 ADJACENT TECHNOLOGIES
    • 5.10.3.1 Fluorescence imaging/Narrow-band imaging (NBI)
• 5.11 PATENT ANALYSIS
• 5.12 TRADE ANALYSIS
  • 5.12.1 IMPORT DATA FOR HS CODE 901890
  • 5.12.2 EXPORT DATA FOR HS CODE 901890
• 5.13 KEY CONFERENCES AND EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
  • 5.14.1 CASE STUDY 1: AUTOMATED VISUAL INSPECTION FOR RIGID ENDOSCOPES
  • 5.14.2 CASE STUDY 2: MINIMALLY INVASIVE DIAGNOSIS OF PERIPHERAL PULMONARY LESION VIA RADIAL PROBE EBUS AND GUIDE SHEATH
  • 5.14.3 CASE STUDY 3: OPTIMIZING TRANSBRONCHIAL CRYOBIOPSY IN INTERSTITIAL LUNG DISEASE USING AMBU ASCOPE 5 BRONCHO HD
• 5.15 REGULATORY LANDSCAPE
  • 5.15.1 REGULATORY ANALYSIS
    • 5.15.1.1 NORTH AMERICA
      • 5.15.1.1.1 US
      • 5.15.1.1.2 Canada
    • 5.15.1.2 Europe
    • 5.15.1.3 Asia Pacific
      • 5.15.1.3.1 Japan
      • 5.15.1.3.2 China
      • 5.15.1.3.3 India
    • 5.15.1.4 Latin America
    • 5.15.1.5 Middle East & Africa
  • 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.16 PORTER'S FIVE FORCES ANALYSIS
  • 5.16.1 BARGAINING POWER OF SUPPLIERS
  • 5.16.2 BARGAINING POWER OF BUYERS
  • 5.16.3 THREAT OF NEW ENTRANTS
  • 5.16.4 THREAT OF SUBSTITUTES
  • 5.16.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.17 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.17.2 KEY BUYING CRITERIA
• 5.18 ADJACENT MARKET ANALYSIS
  • 5.18.1 FLEXIBLE ENDOSCOPES MARKET
• 5.19 UNMET NEEDS
• 5.20 IMPACT OF AI ON ENDOSCOPY EQUIPMENT MARKET
  • 5.20.1 INTRODUCTION
  • 5.20.2 MARKET POTENTIAL OF AI ON ENDOSCOPY EQUIPMENT ECOSYSTEM
  • 5.20.3 AI USE CASES
  • 5.20.4 KEY COMPANIES IMPLEMENTING AI
  • 5.20.5 FUTURE OF GENERATIVE AI ON ENDOSCOPY EQUIPMENT MARKET
• 5.21 IMPACT OF 2025 US TARIFFS
  • 5.21.1 INTRODUCTION
  • 5.21.2 KEY TARIFF RATES
  • 5.21.3 PRICE IMPACT ANALYSIS
  • 5.21.4 IMPACT ON REGION
    • 5.21.4.1 North America
    • 5.21.4.2 Europe
    • 5.21.4.3 Asia Pacific
  • 5.21.5 END-USE INDUSTRY IMPACT

6 ENDOSCOPY EQUIPMENT MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 VISUALIZATION SYSTEMS
  • 6.2.1 WIRELESS DISPLAYS & MONITORS
    • 6.2.1.1 Ability to enhance surgical efficiency, flexibility, and cost-effectiveness to spur growth
  • 6.2.2 ENDOSCOPIC LIGHT SOURCES
    • 6.2.2.1 Increasing focus on eco-friendly and cost-saving LED lights to encourage growth
  • 6.2.3 VIDEO CONVERTERS
    • 6.2.3.1 Growing need for high-resolution images and videos to propel market
  • 6.2.4 VIDEO RECORDERS
    • 6.2.4.1 Increasing need for high-quality documentation and efficient data management to support growth
  • 6.2.5 VIDEO PROCESSORS
    • 6.2.5.1 Enhanced image quality, procedural accuracy, and operational efficiency capabilities to aid growth
  • 6.2.6 CAMERA HEADS
    • 6.2.6.1 HD cameras
      • 6.2.6.1.1 Increasing need for technologically advanced cameras to augment growth
    • 6.2.6.2 4K cameras
      • 6.2.6.2.1 Growing use of 4K cameras during surgeries to boost market
    • 6.2.6.3 3D cameras
      • 6.2.6.3.1 Superior depth perception to contribute to growth
    • 6.2.6.4 3-chip cameras
      • 6.2.6.4.1 Improved image and video quality to bolster growth
    • 6.2.6.5 Single-chip cameras
      • 6.2.6.5.1 Affordability and compact design to facilitate growth
  • 6.2.7 CARTS
    • 6.2.7.1 Ability to reduce damage and minimize contamination to stimulate growth
  • 6.2.8 TRANSMITTERS & RECEIVERS
    • 6.2.8.1 Increased compatibility with multiple devices to expedite growth
  • 6.2.9 OTHER VISUALIZATION SYSTEMS
• 6.3 ENDOSCOPES
  • 6.3.1 FLEXIBLE ENDOSCOPES
    • 6.3.1.1 Upper gastrointestinal endoscopes
      • 6.3.1.1.1 Upper gastrointestinal videoscopes
      • 6.3.1.1.2 Upper gastrointestinal fiberscopes
    • 6.3.1.2 Colonoscopes
      • 6.3.1.2.1 Video colonoscopes
      • 6.3.1.2.2 Fiber colonoscopes
    • 6.3.1.3 Sigmoidoscopes
      • 6.3.1.3.1 Video sigmoidoscopes
      • 6.3.1.3.2 Fiber sigmoidoscopes
    • 6.3.1.4 Bronchoscopes
      • 6.3.1.4.1 Video bronchoscopes
      • 6.3.1.4.2 Fiber bronchoscopes
    • 6.3.1.5 Laryngoscopes
      • 6.3.1.5.1 Video laryngoscopes
      • 6.3.1.5.2 Fiber laryngoscopes
    • 6.3.1.6 Pharyngoscopes
      • 6.3.1.6.1 Video pharyngoscopes
      • 6.3.1.6.2 Fiber pharyngoscopes
    • 6.3.1.7 Duodenoscopes
      • 6.3.1.7.1 Video duodenoscopes
      • 6.3.1.7.2 Fiber duodenoscopes
    • 6.3.1.8 Nasopharyngoscopes
      • 6.3.1.8.1 Video nasopharyngoscopes
      • 6.3.1.8.2 Fiber nasopharyngoscopes
    • 6.3.1.9 Rhinoscopes
      • 6.3.1.9.1 Video rhinoscopes
      • 6.3.1.9.2 Fiber rhinoscopes
    • 6.3.1.10 Other flexible endoscopes
      • 6.3.1.10.1 Other flexible video endoscopes
      • 6.3.1.10.2 Other flexible fiber endoscopes
  • 6.3.2 RIGID ENDOSCOPES
    • 6.3.2.1 Laparoscopes
      • 6.3.2.1.1 Increasing use of laparoscopes in diagnostic and therapeutic procedures to favor growth
    • 6.3.2.2 Urology endoscopes
      • 6.3.2.2.1 Rising prevalence of urological disorders to speed up growth
    • 6.3.2.3 Gynecology endoscopes
      • 6.3.2.3.1 Growing disease burden to drive market
    • 6.3.2.4 Arthroscopes
      • 6.3.2.4.1 Rising global geriatric population and growing incidence of orthopedic diseases to propel market
    • 6.3.2.5 Cystoscopes
      • 6.3.2.5.1 Increasing prevalence of bladder-related disorders and cancers to intensify growth
    • 6.3.2.6 Neuroendoscopes
      • 6.3.2.6.1 Reduced trauma, faster recovery times, and access to deep-seated regions to aid growth
    • 6.3.2.7 Other rigid endoscopes
  • 6.3.3 CAPSULE ENDOSCOPES
    • 6.3.3.1 Rising demand for patient-friendly diagnostics, technological advancements, and favorable reimbursement policies to fuel market
  • 6.3.4 ROBOT-ASSISTED ENDOSCOPES
    • 6.3.4.1 Continuous technological innovations and increasing FDA approvals to promote growth
• 6.4 OTHER ENDOSCOPY EQUIPMENT
  • 6.4.1 ELECTRONIC ENDOSCOPY EQUIPMENT
    • 6.4.1.1 Endoscopy fluid management systems
      • 6.4.1.1.1 Growing demand for multifunctional and cost-efficient fluid management systems to drive market
    • 6.4.1.2 Insufflators
      • 6.4.1.2.1 Rising adoption of laparoscopic surgeries to amplify growth
    • 6.4.1.3 Endoscopic ultrasound systems
      • 6.4.1.3.1 Rising global prevalence of gastrointestinal and lung cancers to spur growth
    • 6.4.1.4 Other electronic endoscopy equipment
  • 6.4.2 MECHANICAL ENDOSCOPY EQUIPMENT
    • 6.4.2.1 Biopsy forceps
      • 6.4.2.1.1 Rising demand for accurate and timely cancer diagnosis to expedite growth
    • 6.4.2.2 Graspers
      • 6.4.2.2.1 Precision capabilities to contribute to growth
    • 6.4.2.3 Snares
      • 6.4.2.3.1 Ability to prevent tissue contamination and infections to facilitate growth
    • 6.4.2.4 Trocars & cannulas
      • 6.4.2.4.1 Increasing technological advancements to bolster growth
    • 6.4.2.5 Other mechanical endoscopic equipment
• 6.5 ACCESSORIES
  • 6.5.1 CLEANING BRUSHES
    • 6.5.1.1 Increasing emphasis on infection control and strict regulatory standards to foster growth
  • 6.5.2 BIOPSY VALVES
    • 6.5.2.1 Growing awareness about patient safety to fuel market
  • 6.5.3 OVERTUBES
    • 6.5.3.1 Ability to enhance procedural safety, efficiency, and patient comfort to expedite growth
  • 6.5.4 NEEDLE HOLDERS/FORCEPS
    • 6.5.4.1 Need for reliable, high-quality surgical tools to favor growth
  • 6.5.5 FLUID FLUSHING DEVICES
    • 6.5.5.1 Increasing need for procedural efficiency and enhanced clinical outcomes to bolster growth
  • 6.5.6 LIGHT CABLES
    • 6.5.6.1 Versatile lengths and diameters to facilitate growth
  • 6.5.7 SURGICAL DISSECTORS
    • 6.5.7.1 Increased adoption of minimally invasive procedures to expedite growth
  • 6.5.8 MOUTHPIECES
    • 6.5.8.1 Growing emphasis on patient safety, operator convenience, and infection control to boost market
  • 6.5.9 OTHER ACCESSORIES

7 ENDOSCOPY EQUIPMENT MARKET, BY APPLICATION

• 7.1 INTRODUCTION
• 7.2 GASTROINTESTINAL ENDOSCOPY
  • 7.2.1 GROWING INCIDENCE OF COLORECTAL CANCER, PARTICULARLY IN YOUNGER ADULTS TO FUEL MARKET
• 7.3 LAPAROSCOPY
  • 7.3.1 INCREASING PREVALENCE OF OBESITY AND RISING ADOPTION OF BARIATRIC SURGERIES TO SUPPORT GROWTH
• 7.4 UROLOGY ENDOSCOPY (CYSTOSCOPY)
  • 7.4.1 GROWING BURDEN OF BLADDER-RELATED DISORDERS TO PROPEL MARKET
• 7.5 ARTHROSCOPY
  • 7.5.1 RISE IN SPORTS INJURIES AND GERIATRIC POPULATION TO BOLSTER GROWTH
• 7.6 OBSTETRICS/GYNECOLOGY ENDOSCOPY
  • 7.6.1 INCREASING PREVALENCE OF CERVICAL CANCER TO FACILITATE GROWTH
• 7.7 BRONCHOSCOPY
  • 7.7.1 INCREASING CASES OF LUNG CANCER TO ENCOURAGE GROWTH
• 7.8 ENT ENDOSCOPY
  • 7.8.1 GROWING NEED FOR ADVANCED DIAGNOSTIC TOOLS TO TREAT THROAT, NASAL, AND AIRWAY CONDITIONS TO DRIVE MARKET
• 7.9 MEDIASTINOSCOPY
  • 7.9.1 RISING PREVALENCE OF LYMPHOMA AND OTHER THORACIC CONDITIONS TO AID GROWTH
• 7.10 OTHER APPLICATIONS

8 ENDOSCOPY EQUIPMENT MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HOSPITALS
  • 8.2.1 ADVANCED INFRASTRUCTURE, SPECIALIZED WORKFORCE, AND ABILITY TO HANDLE LARGE PATIENT VOLUMES TO AID GROWTH
• 8.3 AMBULATORY SURGERY CENTERS
  • 8.3.1 GROWING PATIENT PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES WITH SAME-DAY DISCHARGE TO BOOST MARKET
• 8.4 CLINICS
  • 8.4.1 INCREASING PREFERENCE FOR ACCESSIBLE, COST-EFFECTIVE, AND PATIENT-FRIENDLY DIAGNOSTIC AND THERAPEUTIC SERVICES TO AID GROWTH
• 8.5 OTHER END USERS

9 ENDOSCOPY EQUIPMENT MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Advanced healthcare infrastructure and high prevalence of chronic and life-threatening diseases to aid growth
  • 9.2.3 CANADA
    • 9.2.3.1 High cancer and IBD prevalence and advanced healthcare access to propel market
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Robust healthcare spending and high disease burden to aid growth
  • 9.3.3 UK
    • 9.3.3.1 Rising geriatric population and significant hospital investments to stimulate growth
  • 9.3.4 FRANCE
    • 9.3.4.1 Increase in health expenditure and high prevalence of cancer to promote growth
  • 9.3.5 ITALY
    • 9.3.5.1 Increasing demand for gastrointestinal diagnostics and minimally invasive procedures to facilitate growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Increasing cases of colorectal, lung, and bladder cancers to bolster growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Vast patient base, high cancer prevalence, and significant healthcare advancements to propel market
  • 9.4.3 JAPAN
    • 9.4.3.1 Aging population and cancer prevalence to significantly boost demand for endoscopy procedures
  • 9.4.4 INDIA
    • 9.4.4.1 Aging population and growing public awareness of early disease detection to drive market
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 High cancer incidence and widespread adoption of screening programs to aid growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Rise in gastrointestinal disorders to amplify growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing adoption of advanced healthcare technologies to spur growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Booming medical tourism to sustain growth
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Increasing healthcare investments and adoption of advanced medical technologies to drive market
  • 9.6.3 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN ENDOSCOPY EQUIPMENT MARKET
• 10.3 REVENUE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.5.1 COMPANY VALUATION
  • 10.5.2 FINANCIAL METRICS
• 10.6 BRAND/PRODUCT COMPARISON
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Region footprint
    • 10.7.5.3 Type footprint
    • 10.7.5.4 Application footprint
    • 10.7.5.5 End-user footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.8.5.1 Detailed list of key startups/SMEs
    • 10.8.5.2 Competitive benchmarking of key startups/SMEs
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 PRODUCT LAUNCHES AND APPROVALS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 OLYMPUS CORPORATION
    • 11.1.1.1 Business overview
    • 11.1.1.2 Products offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Product launches and approvals
      • 11.1.1.3.2 Deals
      • 11.1.1.3.3 Expansions
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 KARL STORZ SE & CO. KG
    • 11.1.2.1 Business overview
    • 11.1.2.2 Products offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Deals
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 BOSTON SCIENTIFIC CORPORATION
    • 11.1.3.1 Business overview
    • 11.1.3.2 Products offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Product launches and approvals
      • 11.1.3.3.2 Deals
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 STRYKER
    • 11.1.4.1 Business overview
    • 11.1.4.2 Products offered
    • 11.1.4.3 MnM view
      • 11.1.4.3.1 Right to win
      • 11.1.4.3.2 Strategic choices
      • 11.1.4.3.3 Weaknesses and competitive threats
  • 11.1.5 FUJIFILM CORPORATION
    • 11.1.5.1 Business overview
    • 11.1.5.2 Products offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Deals
      • 11.1.5.3.2 Expansions
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 JOHNSON & JOHNSON
    • 11.1.6.1 Business overview
    • 11.1.6.2 Products offered
    • 11.1.6.3 Recent developments
      • 11.1.6.3.1 Product launches and approvals
      • 11.1.6.3.2 Deals
  • 11.1.7 MEDTRONIC
    • 11.1.7.1 Business overview
    • 11.1.7.2 Products offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 HOYA CORPORATION
    • 11.1.8.1 Business overview
    • 11.1.8.2 Products offered
    • 11.1.8.3 Recent developments
      • 11.1.8.3.1 Product launches and approvals
      • 11.1.8.3.2 Deals
  • 11.1.9 NIPRO
    • 11.1.9.1 Business overview
    • 11.1.9.2 Products offered
  • 11.1.10 SMITH+NEPHEW
    • 11.1.10.1 Business overview
    • 11.1.10.2 Products offered
  • 11.1.11 STERIS
    • 11.1.11.1 Business overview
    • 11.1.11.2 Products offered
    • 11.1.11.3 Recent developments
      • 11.1.11.3.1 Deals
      • 11.1.11.3.2 Expansions
  • 11.1.12 AMBU A/S
    • 11.1.12.1 Business overview
    • 11.1.12.2 Products offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Product launches and approvals
      • 11.1.12.3.2 Expansions
  • 11.1.13 RICHARD WOLF GMBH
    • 11.1.13.1 Business overview
    • 11.1.13.2 Products offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Deals
  • 11.1.14 INTUITIVE SURGICAL OPERATIONS, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Products offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Product launches and approvals
  • 11.1.15 B. BRAUN SE
    • 11.1.15.1 Business overview
    • 11.1.15.2 Products offered
• 11.2 OTHER PLAYERS
  • 11.2.1 HOLOGIC, INC.
  • 11.2.2 CONMED CORPORATION
  • 11.2.3 TELEFLEX INCORPORATED
  • 11.2.4 SONOSCAPE MEDICAL CORP.
  • 11.2.5 ENDOMED SYSTEMS GMBH
  • 11.2.6 HUNAN VATHIN MEDICAL INSTRUMENT CO., LTD.
  • 11.2.7 CAPSOVISION, INC.
  • 11.2.8 ATMOS MEDIZINTECHNIK GMBH & CO. KG
  • 11.2.9 LABORIE
  • 11.2.10 ZHUHAI PUSEN MEDICAL TECHNOLOGY CO., LTD.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS